Stay updated on Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial page
- Check2 days agoChange DetectedNo additions or deletions were detected on the Study Details page for NCT02781506. The page content and structure appear unchanged.SummaryDifference0.5%

 - Check9 days agoNo Change Detected
 - Check30 days agoChange Detected- Added a broad government funding and operating-status notice and updated to v3.2.0. - Removed the specific resource “Clear cell carcinoma of kidney” from Genetic and Rare Diseases Information Center.SummaryDifference3%

 - Check37 days agoChange DetectedTerminology refined from "Clear cell renal carcinoma" to "Clear cell carcinoma of kidney" and software/version update to v3.1.0.SummaryDifference0.2%

 - Check52 days agoChange DetectedRevision updated to v3.0.2, replacing v3.0.1. Removed the 'Back to Top' link as a minor UI change.SummaryDifference0.2%

 - Check59 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.2%

 - Check66 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, as well as updates to the classification of renal cell carcinoma and related antibodies. Notably, the revision number has been updated to v3.0.0.SummaryDifference4%

 
Stay in the know with updates to Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial page.